All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2006-000251-18 | Phase II Cardiac Safety trial of liposomal pegillated doxorrubicine in patients with breast cancer with non evidence of disease and previous exposition to Antraciclines. Estudio Fase II de Seguridad... | not-yet-due | |
Ongoing | 2011-005031-96 | ?Estudio fase IIa, de farmacocinética y farmacodinámica, para confirmar el efecto inhibidor de temsirolimus sobre la vía mTOR en el cáncer de endometrio? | not-yet-due |